Showing results for Cancer

IU cancer researchers refining colorectal cancer classification, identifying new targets for treatment using cutting-edge, single-cell technology

Analyzing nearly 500,000 single cells, researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center are refining how to classify colorectal cancer and identify new targets to develop effective therapies.

IU School of Medicine | May 23, 2022

IU School of Medicine names first Walther Scholar in Psycho-Oncology

Indiana University School of Medicine has named Shelley Johns, PsyD, ABPP, the Walther Scholar in Psycho-Oncology.

IU School of Medicine | Apr 26, 2022

Vera Bradley Foundation for Breast Cancer makes $12.5 million commitment to Indiana University School of Medicine

A gift commitment of $12.5 million to Indiana University School of Medicine from the Vera Bradley Foundation for Breast Cancer will support new research to harness immunotherapy for breast cancer treatment.

IU School of Medicine | Apr 20, 2022

Study: Vaccine protects most cancer patients from COVID, but risk remains higher for patients with blood cancers

Using the nation’s largest COVID-19 data resource, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found the COVID-19 vaccine protected most cancer patients from getting COVID.

IU School of Medicine | Apr 04, 2022

Researchers make important new findings about how to test cancer-fighting drugs

Researchers from Indiana University School of Medicine are discovering new ways to find out how effective a drug might be against cancer.

Christina Griffiths | Jan 13, 2022

IU School of Medicine research provides advances in treatment of triple negative breast cancer

Indiana University School of Medicine physician scientist Bryan Schneider, MD is the principal investigator of clinical trial BRE12-158, a randomized clinical study published in the prominent Journal of Clinical Oncology the primary goal of which was to compare survival in women with high-risk (those who did not fully respond to chemotherapy prior to surgery) triple negative breast cancer (TNBC) with a genomically directed therapy versus standard of care.

IU School of Medicine | Dec 15, 2021

IU Simon Comprehensive Cancer Center auto racing

IU Simon Comprehensive Cancer Center enters into sponsorship with Indiana racing driver Jackson Lee

Marking 30 years of accelerating lifesaving research, the Indiana University Melvin and Bren Simon Comprehensive Cancer Center is putting the pedal to the metal through a new auto racing sponsorship.

IU School of Medicine | Dec 06, 2021

IU cancer researcher leads national work focused on developing treatments for inherited childhood cancers

An Indiana University cancer researcher is leading an $11.4 million grant from the National Cancer Institute in which he and others across the country will work on identifying new treatments for tumors that develop in children, adolescents and adults with a common genetic condition.

IU School of Medicine | Nov 18, 2021

Rikki Goldstein lung cancer research funding

$2 million gift supports lung, pancreatic cancer research at IU

In a gesture that defines gratitude and respect spanning more than 23 years, Carmel resident Ruth “Rikki” Kutcher Goldstein has made a $2 million gift to support cancer research at Indiana University School of Medicine.

IU School of Medicine | Nov 11, 2021

IU School of Medicine launches new study to develop personalized therapies for triple-negative breast cancer patients

Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide study to better understand how to treat patients with triple-negative breast cancer based on their own unique genetic data.

IU School of Medicine | Oct 26, 2021